16 December 2019
Integumen PLC
("Integumen" or "Company")
Director/PDMR Shareholdings
Further to the announcement released by the Company on 9 December 2019, and following admission of 91,253,530 new Ordinary Shares to trading on AIM ("Admission") this morning, Integumen announces the following PDMR Shareholdings arising as a result of the Ordinary Shares issued and allotted pursuant to the Subscription.
The following table sets out details of the Directors' share dealings and resulting interests in the Company's issued share capital:
|
Director |
Shares subscribed for on 9 December 2019 |
Resulting interest |
Resulting interest (%) |
|
Gerard Brandon |
1,084,511 |
50,199,012 |
4.68% |
|
Camillus Glover |
1,084,510 |
42,506,704 |
3.96% |
|
Fionán Murray |
1,084,510 |
87,867,578 |
8.19% |
Total Voting Rights
Following Admission, the Company's issued share capital consists of 1,072,416,903 ordinary shares of 0.01 pence each.
The above figure of 1,072,416,903 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.
Market Abuse Regulation (MAR) Disclosure
Certain information contained in this announcement would have been deemed inside information for the purposes of Article 7 of Regulation (EU) No 596/2014 until the release of this announcement.
Capitalised terms used in this announcement shall have the same meaning as in the announcement released by the Company on 9 December 2019.
Enquiries:
|
Integumen plc |
Gerard Brandon, CEO |
+44 (0) 7340 055 648 |
|
|
|
|
|
SPARK Advisory Partners Limited (Nominated Adviser) |
Neil Baldwin |
+44 (0) 113 370 8974 |
|
|
|
|
|
Turner Pope Investments (TPI) Limited (Broker) |
Andy Thacker/Zoe Alexander |
+44 (0) 20 3657 0050 |
About Integumen: www.integumen.com
Integumen is a vertically integrated product and services company for skin related diseases, treatments and therapies with four business units:
· Labskin AI's technology platform incorporates artificial intelligence within clinical research for medical device, pharmaceuticals, cosmeceuticals and related life science test services. Labskin allows skincare, healthcare, pharmaceutical manufacturers and cosmetic companies to test their products on human-like skin in a real-world environment with full access to multiple state-of-the-art partner technologies.
· Rinodrive is a data aggregation, refining and AI analysis open-source eco-system designed to provide third-party service providers the ability to offer their clients valuable insights that support clinical, operational and financial decisions in healthcare services, third-level education, government departments and the financial sector.
· Wound pHase is developing skin and wound care products using its proprietary wound dressing technology. Working in collaboration with CBD providers creating a CBD infused diabetic wound care product range.
· Stoer-for-men skin products e-commerce division offers a range of skincare products derived from 5 natural super-ingredient plant extracts specifically for men to reduce the signs of ageing and is also used as a control for client testing within Labskin laboratories.
FORM FOR NOTIFYING DEALINGS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM
|
1 |
Details of the person discharging managerial responsibilities/person closely associated |
||||||
|
a) |
Name |
Gerard Brandon |
|||||
|
2 |
Reason for the notification |
||||||
|
a) |
Position/status |
Chief Executive Officer (PDMR) |
|||||
|
b) |
Initial notification/ Amendment |
Initial |
|||||
|
3 |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
||||||
|
a) |
Name |
Integumen PLC |
|||||
|
b) |
LEI |
213800M477RQVVHVUD72 |
|||||
|
4 |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
||||||
|
a) |
Description of the financial instrument, type of instrument Identification code |
Ordinary shares of 0.01 pence each Identification code GB00BYWJ6269
|
|||||
|
b) |
Nature of the transaction |
Acquisition of ordinary shares (subscription) |
|||||
|
c) |
Price(s) and volume(s) |
|
|||||
|
d) |
Aggregated information - Aggregated volume and Price |
Total - £16,267.67 |
|||||
|
e) |
Date of the transaction |
16 December 2019 |
|||||
|
f) |
Place of the transaction |
X.LON |
|||||
|
1 |
Details of the person discharging managerial responsibilities/person closely associated |
||||||
|
a) |
Name |
Camillus Glover
|
|||||
|
2 |
Reason for the notification |
||||||
|
a) |
Position/status |
Chief of Finance and Operations (PDMR) |
|||||
|
b) |
Initial notification/ Amendment |
Initial |
|||||
|
3 |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
||||||
|
a) |
Name |
Integumen PLC |
|||||
|
b) |
LEI |
213800M477RQVVHVUD72 |
|||||
|
4 |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
||||||
|
a) |
Description of the financial instrument, type of instrument Identification code |
Ordinary shares of 0.01 pence each Identification code GB00BYWJ6269
|
|||||
|
b) |
Nature of the transaction |
Acquisition of ordinary shares (subscription) |
|||||
|
c) |
Price(s) and volume(s) |
|
|||||
|
d) |
Aggregated information - Aggregated volume and Price |
Total - £16,267.65 |
|||||
|
e) |
Date of the transaction |
16 December 2019 |
|||||
|
f) |
Place of the transaction |
X.LON |
|||||
|
1 |
Details of the person discharging managerial responsibilities/person closely associated |
||||||
|
a) |
Name |
Fionán Murray |
|||||
|
2 |
Reason for the notification |
||||||
|
a) |
Position/status |
Group Sales Director (PDMR) |
|||||
|
b) |
Initial notification/ Amendment |
Initial |
|||||
|
3 |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
||||||
|
a) |
Name |
Integumen PLC |
|||||
|
b) |
LEI |
213800M477RQVVHVUD72 |
|||||
|
4 |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
||||||
|
a) |
Description of the financial instrument, type of instrument Identification code |
Ordinary shares of 0.01 pence each Identification code GB00BYWJ6269
|
|||||
|
b) |
Nature of the transaction |
Acquisition of ordinary shares (subscription) |
|||||
|
c) |
Price(s) and volume(s) |
|
|||||
|
d) |
Aggregated information - Aggregated volume and Price |
Total - £16,267.65 |
|||||
|
e) |
Date of the transaction |
16 December 2019 |
|||||
|
f) |
Place of the transaction |
X.LON |
|||||